Check 35,000+ stocks against 26 valuation models and 37 quality factors

The Bombay Burmah Trading Corporation (501425) fair value: what the stock is really worth

As of Oct 1, 2026: fair value of The Bombay Burmah Trading Corporation ₹4,500, price ₹1,334, upside +237.3%, quality 67 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? Yes
Good quality? Yes
Add to watchlist

Consumer Non-Cyclicals · IN · ISIN INE050A01025

TB Thin data Sep 24, 2026

The Bombay Burmah Trading Corporation

501425 · BSE

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value ₹4,500 · Strongly undervalued (+237.3%)

✓Quality 67/100

✓Healthy Growth (revenue 5y +7.5 %/yr)

!Thin margins · 6.5% net margin (FY2025)

✓Low debt · generates free cash flow

✓Wide moat 67/100

!Evidence only low, so the estimate is less certain

26 models, one by oneBear ₹3,375 to bull ₹5,626 Growth analysisrevenue history, year by year Quality 67/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch The Bombay Burmah Trading Corporation for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range ₹767.31 – ₹2,832 · fair‑value band ₹3,375 – ₹5,626 · the ₹1,334 price screens below the ₹4,500 fair value. Dashed = 300-day average. As of Sep 24, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

The Bombay Burmah Trading Corporation, Limited, together with its subsidiaries, engages in plantation, auto electric components, weighing products, investments, health care, horticulture, real estate, and food businesses in India and internationally. The company's Plantation-Tea segment produces and trades in tea. Its Plantation-Coffee segment produces and trades in coffee. The company's Auto Electric Components segment manufactures solenoids, switches, valves, slip rings, etc. for automobile and other industries. Its Weighing Products segment manufactures and trades in analytical and precision balances, and weighing scales. The company's Investments segment invests in various securities listed, as well as unlisted primarily on a long-term basis. Its Health Care segment manufactures and trades in healthcare/dental products. The company's Horticulture segment deals with decorative plants and landscaping services. Its Real Estate segment develops properties. The company's Food??Bakery and Dairy Products segment offers bakery and dairy products. The company also produces and trades in timber, cardamom, and pepper. The Bombay Burmah Trading Corporation, Limited was founded in 1863 and is based in Mumbai, India.

Stock analysis

The Bombay Burmah Trading Corporation (501425) currently trades at ₹1,334, while our model-based Fair Value estimate is ₹4,500, implying the stock looks roughly 70.4% undervalued today.

Valuation

Bull case: the Growth DCF group reads highest at a median of ₹4,926 per share, and 23 of the 24 models we run sit above the ₹1,334 price.

Bear case: the Asset-Based group reads lowest at ₹739.61, and 1 of the 24 models stay below the price. Evidence for this calculation is low.

Scenario range: ₹3,375 (bear) to ₹5,626 (bull), the price of ₹1,334 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 67/100 (solid quality), in the Consumer Non-Cyclicals sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

The Bombay Burmah Trading Corporation reported revenue of ₹192B in FY2025 versus ₹145B in FY2021, a compound +7.3%/yr. Reported net income was ₹12.4B in FY2025, compounding +110.4%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.

Key figures

Market cap ₹93.1B (≈ $967M) · P/E ratio 14.2 · P/S ratio 0.92 · EPS (TTM) ₹85.74 · Dividend yield 11.9% · Net margin 6.5% · Return on assets (EBIT) 17.1% · Free cash flow ₹21.9B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 36% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at −24% fair-value upside, at 237%, 501425 screens cheaper than that median.

Fair Value models

Bear ₹3,375 Fair Value ₹4,500 Bull ₹5,626

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (₹64.84 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF ₹3,506 ₹5,152 ₹7,393 80

Growth DCF ₹3,517 ₹4,926 ₹6,717 79

Owner Earnings ₹2,271 ₹3,325 ₹4,762 76

All 24 models by family

DCF Models

FCF DCF ₹3,506 ₹5,152 ₹7,393 80

Owner Earnings ₹2,271 ₹3,325 ₹4,762 76

5Y Revenue Exit ₹3,248 ₹5,056 ₹7,361 72

5Y EBITDA Exit ₹4,293 ₹7,039 ₹10,269 74

5Y P/E Exit ₹3,074 ₹4,725 ₹6,459 71

10Y Revenue Exit ₹3,231 ₹4,822 ₹6,960 66

10Y EBITDA Exit ₹3,926 ₹6,090 ₹9,015 68

10Y P/E Exit ₹3,211 ₹4,610 ₹6,323 64

Earnings-Based

Graham-Dodd ₹1,325 ₹4,438 ₹5,944 64

Lynch FV ₹1,009 ₹1,442 ₹1,874 61

PEG = 1.0 ₹1,009 ₹1,442 ₹1,874 57

EPV ₹3,178 ₹3,603 ₹3,956 71

Multiples

P/E Multiple ₹3,068 ₹4,091 ₹5,114 63

P/S Multiple ₹2,484 ₹3,312 ₹4,140 58

P/B Multiple ₹2,484 ₹3,312 ₹4,140 55

EV/EBIT ₹6,345 ₹8,438 ₹10,532 66

EV/EBITDA ₹5,406 ₹7,186 ₹8,966 67

EV/Revenue ₹3,233 ₹4,590 ₹5,947 53

Asset-Based

NCAV (Graham) ₹551.95 ₹739.61 ₹1,104 54

Growth DCF

Growth DCF ₹3,517 ₹4,926 ₹6,717 79

Rev-Margin DCF ₹3,248 ₹5,068 ₹7,206 72

Economic Profit

Residual Income ₹1,111 ₹1,409 ₹2,040 75

ROIC Compounder ₹3,358 ₹4,018 ₹4,708 72

Growth Earnings

Growth-Adj P/E ₹2,604 ₹3,720 ₹4,836 67

Open the full fair value analysis →

Notify me when 501425 reaches fair value

Put 501425 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 67/100

Of which business quality 66 · Market factors (momentum, volatility) 31

Profitability 69

Margins and returns on capital today

Quality Growth 22

Are margins and returns improving?

Cashflow 73

Earnings quality: real cash, not paper profit

Fin. Strength 75

Balance sheet, leverage, solvency risk

Investment 67

Disciplined investing over empire-building

Low Volatility 59

Calm price path (market factor)

Momentum 29

Price trend over the last 3–12 months (market factor)

52W Momentum 1

Distance to the 52-week high (market factor)

Net Issuance 82

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 75/100

Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Revenue growth 1 year

+5.2%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+5.0%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+7.5%

Start year 2020 (pandemic). Over 10 years: +7.9% a year

Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+7.9%

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.

+21.3%

Earnings growth per share plus dividend.

Earnings per share, growth per year+9.4%

Dividend (yield on the price)11.9%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.27.5% vs 11.4%, picking up

Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.17% → 16%

Start year 2020 (pandemic)

Growth Forecast

Little optimism in the price

The price assumes less growth than the company has delivered so far.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

−12.3%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect

n/a

No analyst forecast available.

After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about −15.8% a year for the price.

Watch 501425, get fair value alerts →

Compare The Bombay Burmah Trading Corporation with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Food & Tobacco · 25 stocks

Beats the industry median on 7/8 measures

Overall it ranks above its industry peers.

Valuation

Quality Score 67 · Top 25%

Profitability

Return on assets 0.0% · Above median

Net margin (TTM) 0.0% · Bottom 25%

Operating margin (TTM) 0.0% · Above median

Growth and dividend

Revenue growth 0.0% · Above median

Dividend yield (TTM) 11.9% · Top 25%

Balance sheet

Debt / equity 0.04× · Below median

Valuation Multiplesvs Food & Tobacco median · lower = cheaper

P/E (TTM) 14.2× · Cheaper than median

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Tobacco

Similar stocks

10 more Food & Tobacco stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
FB FB	44.40 PHP	35.45 PHP	−20%
URC URC	59.20 PHP	39.44 PHP	−33%
MONDE MONDE	6.07 PHP	0.6600 PHP	−89%
CNPF CNPF	32.20 PHP	56.26 PHP	+75%
DNL DNL	3.40 PHP	1.76 PHP	−48%
RFM RFM	5.03 PHP	7.77 PHP	+54%
AXLM AXLM	2.63 PHP	2.00 PHP	−24%
EASY BIO,Inc. 353810	6,090 KRW	17,633 KRW	+190%
Helixmith Co 084990	3,830 KRW	774.11 KRW	−80%
LFM LFM	22.65 PHP	3.21 PHP	−86%

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

The Bombay Burmah Trading Corporation · Fair Value
₹4,500 +70%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/501425" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">The Bombay Burmah Trading Corporation · Fair Value</span><br><b style="font-size:20px">₹4,500</b> <span style="color:var(--fvc-g-mitte);font-weight:700;font-size:14px">+70%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "The Bombay Burmah Trading Corporation Fair Value". https://www.fairvalue-calculator.com/stock/501425

Frequently asked questions

Is The Bombay Burmah Trading Corporation (501425) overvalued or undervalued?

As of Sep 24, 2026, our model estimates a fair value of ₹4,500 versus a price of ₹1,334, about +237% upside (undervalued).

What is the fair value of 501425?

Our model-based fair value for The Bombay Burmah Trading Corporation is ₹4,500 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹1,334.

What is the quality score of 501425?

The Bombay Burmah Trading Corporation has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for The Bombay Burmah Trading Corporation (501425)?

Our model-based price target is the fair value of ₹4,500 (as of Sep 24, 2026) from 24 valuation models. Cautious scenario ₹3,375, optimistic scenario ₹5,626. It is a calculation from audited fundamentals, not an analyst target.

What is the The Bombay Burmah Trading Corporation stock forecast for 2026?

Our models put fair value at ₹4,500, about +237% upside versus a price of ₹1,334 (undervalued). Cautious scenario ₹3,375, optimistic scenario ₹5,626. The calculation is refreshed regularly with new filings.

Does The Bombay Burmah Trading Corporation pay a dividend?

The Bombay Burmah Trading Corporation currently shows a dividend yield of about 11.88% relative to its recent price (as of Sep 24, 2026).

What growth is priced into The Bombay Burmah Trading Corporation (501425)?

For today's price to be fair in a discounted-cash-flow model, The Bombay Burmah Trading Corporation would have to grow free cash flow by -12.3 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.5 % per year. As of Sep 24, 2026.

What discount rate (WACC) does the fair value of 501425 use?

Our models discount The Bombay Burmah Trading Corporation at 13.9 %: a base by market capitalisation (small), country premium for India. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For The Bombay Burmah Trading Corporation that is -12.3 % per year a year over ten years, using the same discount rate (13.9 %) and the same formula as our fair value.

How much growth has The Bombay Burmah Trading Corporation (501425) delivered so far?

Over the past 5 years revenue at The Bombay Burmah Trading Corporation grew +7.5 % a year. The price currently implies -12.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of The Bombay Burmah Trading Corporation (501425) growing?

The median revenue growth in the sector is +2.9 % a year. That is the yardstick for the growth priced into The Bombay Burmah Trading Corporation (-12.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of The Bombay Burmah Trading Corporation (501425)?

The free-cash-flow yield on the price is 23.48 %: that much free cash flow The Bombay Burmah Trading Corporation produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of The Bombay Burmah Trading Corporation (501425)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For The Bombay Burmah Trading Corporation it is ₹4,500 per share (as of Sep 24, 2026), against a price of ₹1,334. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).

Is The Bombay Burmah Trading Corporation stock overvalued or undervalued in 2026?

As of Sep 24, 2026, 501425 trades below its calculated fair value: price ₹1,334, fair value ₹4,500, a gap of about +237% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of 501425?

No. The price is what the market pays today (₹1,334); the fair value is what the company's own numbers justify (₹4,500). For The Bombay Burmah Trading Corporation the two are ₹3,166 per share apart. That gap is exactly why we show both numbers side by side.

How much is The Bombay Burmah Trading Corporation worth?

The market values The Bombay Burmah Trading Corporation at about ₹93.1B (market capitalisation, as of Sep 24, 2026). Per share that is ₹1,334; our models calculate a fair value of ₹4,500 per share.

What do the bullish and bearish scenarios say about 501425?

Our models span a range for The Bombay Burmah Trading Corporation: cautious scenario ₹3,375, base ₹4,500, optimistic ₹5,626 per share (as of Sep 24, 2026, price ₹1,334). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of 501425?

The Bombay Burmah Trading Corporation trades at a price-to-earnings ratio of 14.2 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹4,500 is built from several models across several years.

How solid is the balance sheet of The Bombay Burmah Trading Corporation (501425)?

Balance-sheet figures for The Bombay Burmah Trading Corporation (as of Sep 24, 2026): debt of 0.04 per unit of equity. They feed the Quality Score of 67/100, which measures business quality independently of the share price.

How far is 501425 from its 52-week high?

The Bombay Burmah Trading Corporation trades at ₹1,334, about 36% below its 52-week high of ₹2,082 and 1% above the low of ₹1,321 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹4,500 is for.

Which stocks are comparable to The Bombay Burmah Trading Corporation?

From the same area (Consumer Non-Cyclicals) we also value FB, URC, MONDE, CNPF, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is The Bombay Burmah Trading Corporation stock attractive at the current price?

The data as of Sep 24, 2026: price ₹1,334, calculated fair value ₹4,500 (+237%), Quality Score 67/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of 501425 calculated?

We run The Bombay Burmah Trading Corporation through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹4,500, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.5 % above its aggregate fair value. The Bombay Burmah Trading Corporation currently trades 70 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of The Bombay Burmah Trading Corporation (501425)?

The closing price on Oct 1, 2026 was ₹1,334. Our model-based fair value is ₹4,500, about +237% upside (undervalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with The Bombay Burmah Trading Corporation right now?

The price is below even our cautious bear case (₹3,375). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (67/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of The Bombay Burmah Trading Corporation

How large is the market capitalisation of The Bombay Burmah Trading Corporation (501425)?

The market capitalisation of The Bombay Burmah Trading Corporation is ₹93.1B (≈ $967M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of The Bombay Burmah Trading Corporation (501425)?

The price-to-sales ratio of The Bombay Burmah Trading Corporation is 0.92 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of The Bombay Burmah Trading Corporation (501425)?

Earnings per share at The Bombay Burmah Trading Corporation are ₹85.74 (price ÷ EPS = P/E 14.2). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of The Bombay Burmah Trading Corporation (501425)?

The dividend yield of The Bombay Burmah Trading Corporation is 11.9% (payout 185%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of The Bombay Burmah Trading Corporation (501425)?

The net margin of The Bombay Burmah Trading Corporation is 6.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the EBIT return on assets of The Bombay Burmah Trading Corporation (501425)?

On an EBIT basis the return on assets of The Bombay Burmah Trading Corporation is 17.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

How much net debt does The Bombay Burmah Trading Corporation (501425) carry?

The net debt of The Bombay Burmah Trading Corporation is ₹8.5B (fiscal year 2025, ≈ 0.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch The Bombay Burmah Trading Corporation in the live analysis

One click puts The Bombay Burmah Trading Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.